News

PhD candidate Raafiah Mussa (UCL Queen Square Institute of Neurology) writes with Siobhan McLernon of South Bank University about the many challenges stroke survivors face and calls for increased ongoing NHS care and psychological support.

The UCLB pharmaceutical spinout, EpilepsyGTx which is developing new treatments for refractory epilepsy, has raised $33 million USD (£24.78 million) in Series A funding to bring its gene therapy to clinical trials.

Five UCL academics have received prestigious European Union-funded grants to support research for the next five years in projects covering economics, criminal governance, and neuroscience.

We're delighted that Dr Mena Farag (UCL Queen Square Institute of Neurology) was awarded the UK DRI PhD Prize on 9th December 2025 at Connectome 2025.

Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology) has been named in Nature's 10 list, recognising the people involved in the most influential and important developments this year.

The latest Neuromuscular Diseases (NMD) Research Day took place in November 2025, bringing together clinicians, researchers, and partners to strengthen the future of NMD research.